iShares U.S. Healthcare ETF (IYH) is a publicly traded the market company. As of May 21, 2026, IYH trades at $61.86 with a market cap of $0 and a P/E ratio of 0.00. IYH moved +0.05% today. Year to date, IYH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IYH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AbbVie’s ABBV-295 Yields 7.75%-9.79% Weight Loss in Phase 1 Trial: AbbVie’s ABBV-295 obesity drug achieved mean weight reductions of 7.75% to 9.79% at week 12 across 2-14 mg dosing in a Phase 1 study. AbbVie represents 6.57% of the IYH ETF, so strong ABBV stock performance could lift ETF returns.
| Metric | Value |
|---|---|
| Price | $61.86 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 402.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
IYH analyst coverage data. Average price target: $0.00.